{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T18:03:04Z","timestamp":1781373784861,"version":"3.54.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T00:00:00Z","timestamp":1714867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T00:00:00Z","timestamp":1714867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09542-1","type":"journal-article","created":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T15:01:27Z","timestamp":1714921287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Therapeutic potential of Lactobacillus casei and Chlorella vulgaris in high-fat diet-induced non-alcoholic fatty liver disease (NAFLD)-associated kidney damages: a stereological study"],"prefix":"10.1007","volume":"51","author":[{"given":"Haniyeh","family":"Keyghobadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadis","family":"bozorgpoursavadjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Koohpeyma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Mohammadipoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Nemati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Dehghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Jamhiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamhossein","family":"Keighobadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8553-9221","authenticated-orcid":false,"given":"Sanaz","family":"Dastghaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,5]]},"reference":[{"key":"9542_CR1","doi-asserted-by":"crossref","first-page":"e0288666","DOI":"10.1371\/journal.pone.0288666","volume":"18","author":"J Choi","year":"2023","unstructured":"Choi J, Joe H, Oh J-E, Cho Y-J, Shin H-S, Heo NH (2023) The correlation between NAFLD and serum uric acid to serum creatinine ratio. PLoS ONE 18:e0288666","journal-title":"PLoS ONE"},{"key":"9542_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-022-00980-1","volume":"22","author":"S Pouwels","year":"2022","unstructured":"Pouwels S, Sakran N, Graham Y et al (2022) Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disorders 22:1\u20139","journal-title":"BMC Endocr Disorders"},{"key":"9542_CR3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11901-019-00500-1","volume":"18","author":"RK Pai","year":"2019","unstructured":"Pai RK (2019) NAFLD histology: a critical review and comparison of scoring systems. Curr Hepatol Rep 18:473\u2013481","journal-title":"Curr Hepatol Rep"},{"key":"9542_CR4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12944-021-01485-x","volume":"20","author":"X Zheng","year":"2021","unstructured":"Zheng X, Cao C, He Y, Wang X, Wu J, Hu H (2021) Association between nonalcoholic fatty liver disease and incident diabetes mellitus among Japanese: a retrospective cohort study using propensity score matching. Lipids Health Dis 20:59","journal-title":"Lipids Health Dis"},{"key":"9542_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-019-1136-4","volume":"20","author":"M Zhang","year":"2020","unstructured":"Zhang M, Lin S, Wang M-f et al (2020) Association between NAFLD and risk of prevalent chronic kidney disease: why there is a difference between east and west? BMC Gastroenterol 20:1\u20137","journal-title":"BMC Gastroenterol"},{"key":"9542_CR6","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.3390\/ijms23137007","volume":"23","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Lombardi R, Cattazzo F, Zusi C, Cappelli D, Dalbeni A (2022) MAFLD and CKD: an updated narrative review. Int J Mol Sci 23:7007\u20137007","journal-title":"Int J Mol Sci"},{"key":"9542_CR7","doi-asserted-by":"crossref","first-page":"13320","DOI":"10.3390\/ijms232113320","volume":"23","author":"A Lonardo","year":"2022","unstructured":"Lonardo A, Mantovani A, Targher G, Baffy G (2022) Nonalcoholic fatty liver disease and chronic kidney disease: epidemiology, pathogenesis, and clinical and research implications. Int J Mol Sci 23:13320\u201313320","journal-title":"Int J Mol Sci"},{"key":"9542_CR8","doi-asserted-by":"crossref","first-page":"e040970","DOI":"10.1136\/bmjopen-2020-040970","volume":"10","author":"T Hydes","year":"2020","unstructured":"Hydes T, Buchanan R, Kennedy OJ, Fraser S, Parkes J, Roderick P (2020) Systematic review of the impact of non-alcoholic fatty liver disease on mortality and adverse clinical outcomes for individuals with chronic kidney disease. BMJ Open 10:e040970\u2013e040970","journal-title":"BMJ Open"},{"key":"9542_CR9","doi-asserted-by":"crossref","first-page":"1617805","DOI":"10.1155\/2020\/1617805","volume":"2020","author":"A Gonzalez","year":"2020","unstructured":"Gonzalez A, Huerta-Salgado C, Orozco-Aguilar J et al (2020) Role of oxidative stress in hepatic and extrahepatic dysfunctions during nonalcoholic fatty liver Disease (NAFLD). Oxidative Med Cell Longev 2020:1617805\u20131617805","journal-title":"Oxidative Med Cell Longev"},{"key":"9542_CR10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fmed.2021.595371","volume":"8","author":"AP Delli Bovi","year":"2021","unstructured":"Delli Bovi AP, Marciano F, Mandato C, Siano MA, Savoia M, Vajro P (2021) Oxidative stress in non-alcoholic fatty liver disease. An updated mini review. Front Med 8:165\u2013165","journal-title":"Front Med"},{"key":"9542_CR11","unstructured":"Nielsen S, Schjoedt K, Astrup A et al (2009) Kidney injury molecule 1 (KIM1) and neutrophil gelatinase-associated lipocalin (NGAL) as markers of tubular kidney injury in type 1 diabetic patients"},{"key":"9542_CR12","unstructured":"Abourady AA, Amin SM, Kasem SM, Abdelnaby HH (2020) Measurement of urinary kidney injury molecule-1 level as an early biomarker of renal impairment in overweight\/obese children and adolescents with nonalcoholic fatty liver disease. J Am Sci 16"},{"key":"9542_CR13","doi-asserted-by":"crossref","first-page":"12464","DOI":"10.3390\/ijms232012464","volume":"23","author":"L Chen","year":"2022","unstructured":"Chen L, Lv X, Kan M, Wang R, Wang H, Zang H (2022) Critical overview of hepatic factors that link non-alcoholic fatty liver disease and acute kidney Injury: physiology and therapeutic implications. Int J Mol Sci 23:12464","journal-title":"Int J Mol Sci"},{"key":"9542_CR14","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jhep.2016.05.025","volume":"65","author":"C Francoz","year":"2016","unstructured":"Francoz C, Nadim MK, Durand F (2016) Kidney biomarkers in cirrhosis. J Hepatol 65:809\u2013824","journal-title":"J Hepatol"},{"key":"9542_CR15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jceh.2020.09.001","volume":"11","author":"D David","year":"2021","unstructured":"David D, Eapen CE (2021) What are the current pharmacological therapies for nonalcoholic fatty liver disease? J Clin Experimental Hepatol 11:232\u2013238","journal-title":"J Clin Experimental Hepatol"},{"key":"9542_CR16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12986-023-00748-x","volume":"20","author":"Y Shao","year":"2023","unstructured":"Shao Y, Chen S, Han L, Liu J (2023) Pharmacotherapies of NAFLD: updated opportunities based on metabolic intervention. Nutr Metabolism 20:30","journal-title":"Nutr Metabolism"},{"key":"9542_CR17","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/fermentation8110610","volume":"8","author":"A Abdella","year":"2022","unstructured":"Abdella A, Elbadawy MF, Irmak S, Alamri ES (2022) Hypolipidemic, antioxidant and Immunomodulatory effects of Lactobacillus casei ATCC 7469-Fermented wheat Bran and Spirulina maxima in rats Fed a High-Fat Diet. Fermentation 8:610\u2013610","journal-title":"Fermentation"},{"key":"9542_CR18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3350\/cmh.2020.0125","volume":"27","author":"NY Lee","year":"2021","unstructured":"Lee NY, Shin MJ, Youn GS et al (2021) Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis. Clin Mol Hepatol 27:110\u2013110","journal-title":"Clin Mol Hepatol"},{"key":"9542_CR19","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3390\/molecules20011118","volume":"20","author":"L Machu","year":"2015","unstructured":"Machu L, Misurcova L, Vavra Ambrozova J et al (2015) Phenolic content and antioxidant capacity in algal food products. Molecules 20:1118\u20131133","journal-title":"Molecules"},{"key":"9542_CR20","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.3390\/foods11121818","volume":"11","author":"M Wan","year":"2022","unstructured":"Wan M, Li Q, Lei Q, Zhou D, Wang S (2022) Polyphenols and polysaccharides from morus alba l. fruit attenuate high-fat diet-induced metabolic syndrome modifying the gut microbiota and metabolite profile. Foods 11:1818\u20131818","journal-title":"Foods"},{"key":"9542_CR21","first-page":"2099","volume":"59","author":"Y Panahi","year":"2012","unstructured":"Panahi Y, Ghamarchehreh ME, Beiraghdar F, Zare R, Jalalian HR, Sahebkar A (2012) Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial. Hepatogastroenterology 59:2099\u20132103","journal-title":"Hepatogastroenterology"},{"key":"9542_CR22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11033-020-05978-3","volume":"48","author":"R Mohseni","year":"2021","unstructured":"Mohseni R, Alavian SM, Sadeghabadi ZA, Heiat M (2021) Therapeutic effects of Chlorella vulgaris on carbon tetrachloride induced liver fibrosis by targeting Hippo signaling pathway and AMPK\/FOXO1 axis. Mol Biol Rep 48:117\u2013126","journal-title":"Mol Biol Rep"},{"key":"9542_CR23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000094303","volume":"50","author":"H-J An","year":"2006","unstructured":"An H-J, Choi H-M, Park H-S et al (2006) Oral administration of hot water extracts of Chlorella vulgaris increases physical stamina in mice. Annals Nutr Metabolism 50:380\u2013386","journal-title":"Annals Nutr Metabolism"},{"key":"9542_CR24","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1017\/S0007114520003013","volume":"125","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Zhou H, Guan M et al (2021) Lactobacillus casei YRL577 combined with plant extracts reduce markers of non-alcoholic fatty liver disease in mice. Br J Nutr 125:1081\u20131091","journal-title":"Br J Nutr"},{"key":"9542_CR25","doi-asserted-by":"crossref","unstructured":"Karp NA, Meehan TF, Morgan H et al (2015) Applying the ARRIVE guidelines to an in vivo database. PLoS Biol 13, e1002151","DOI":"10.1371\/journal.pbio.1002151"},{"key":"9542_CR26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5717\/jenb.2014.18.4.339","volume":"18","author":"J Cho","year":"2014","unstructured":"Cho J, Lee I, Kim D et al (2014) Effect of aerobic exercise training on non-alcoholic fatty liver disease induced by a high fat diet in C57BL\/6 mice. J Exerc Nutr Biochem 18:339","journal-title":"J Exerc Nutr Biochem"},{"key":"9542_CR27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1017\/S0007114520003001","volume":"125","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Zhou H, Zhou X et al (2021) Lactobacillus casei YRL577 ameliorates markers of non-alcoholic fatty liver and alters expression of genes within the intestinal bile acid pathway. Br J Nutr 125:521\u2013529","journal-title":"Br J Nutr"},{"key":"9542_CR28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1309\/LM93W7KTFNPZIXRR","volume":"44","author":"CSH Lim","year":"2013","unstructured":"Lim CSH, Lim SL (2013) Ferric reducing capacity versus ferric reducing antioxidant power for measuring total antioxidant capacity. Lab Med 44:51\u201355","journal-title":"Lab Med"},{"key":"9542_CR29","first-page":"57","volume":"26","author":"W Scherle","year":"1970","unstructured":"Scherle W (1970) A simple method for volumetry of organs in quantitative stereology. Mikroskopie 26:57\u201360","journal-title":"Mikroskopie"},{"key":"9542_CR30","doi-asserted-by":"crossref","first-page":"110490","DOI":"10.1016\/j.cbi.2023.110490","volume":"378","author":"MH Maleki","year":"2023","unstructured":"Maleki MH, Nadimi E, Vakili O et al (2023) Bilirubin improves renal function by reversing the endoplasmic reticulum stress and inflammation in the kidneys of type 2 diabetic rats fed high-fat diet. Chemico-Biol Interact 378:110490","journal-title":"Chemico-Biol Interact"},{"key":"9542_CR31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s40001-023-01114-6","volume":"28","author":"C Roderburg","year":"2023","unstructured":"Roderburg C, Krieg S, Krieg A et al (2023) Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD). Eur J Med Res 28:153\u2013153","journal-title":"Eur J Med Res"},{"key":"9542_CR32","first-page":"107","volume":"4","author":"M Ebrahimi-Mameghani","year":"2014","unstructured":"Ebrahimi-Mameghani M, Aliashrafi S, Javadzadeh Y, AsghariJafarabadi M (2014) The effect of Chlorella vulgaris supplementation on liver enzymes, serum glucose and lipid profile in patients with non-alcoholic fatty liver disease. Health Promotion Perspect 4:107","journal-title":"Health Promotion Perspect"},{"key":"9542_CR33","doi-asserted-by":"crossref","unstructured":"Khani S, Hosseini M, Taheri H, Nourani MR M and, Imani Fooladi A (2012) A Probiotics as an alternative strategy for prevention and treatment of human diseases: a review. Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets-Inflammation & Allergy)(Discontinued) 11, 79\u201389","DOI":"10.2174\/187152812800392832"},{"key":"9542_CR34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1590\/2175-8239-jbn-3931","volume":"40","author":"RAB Fagundes","year":"2018","unstructured":"Fagundes RAB, Soder TF, Grokoski KC, Benetti F, Mendes RH (2018) Probiotics in the treatment of chronic kidney disease: a systematic review. Brazilian J Nephrol 40:278\u2013286","journal-title":"Brazilian J Nephrol"},{"key":"9542_CR35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.21608\/jcvr.2023.320423","volume":"5","author":"MI Elmeleh","year":"2023","unstructured":"Elmeleh MI, Attia T, Elgendy H (2023) Protective effect of Chlorella vulgaris and Spirulina platensis against ThioacetamideInduced Hepatorenal toxicity in male rats. J Curr Veterinary Res 5:79\u201392","journal-title":"J Curr Veterinary Res"},{"key":"9542_CR36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/md20010009","volume":"20","author":"A Regueiras","year":"2021","unstructured":"Regueiras A, Huguet \u00c1, Conde T et al (2021) Potential anti-obesity, anti-steatosis, and anti-inflammatory properties of extracts from the microalgae Chlorella vulgaris and Chlorococcum amblystomatis under different growth conditions. Mar Drugs 20:9","journal-title":"Mar Drugs"},{"key":"9542_CR37","unstructured":"Andy SY, Keeffe EB (2003) Elevated AST or ALT to nonalcoholic fatty liver disease. accurate predictor of disease prevalence?"},{"key":"9542_CR38","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/hepr.13631","volume":"51","author":"Y Imamura","year":"2021","unstructured":"Imamura Y, Mawatari S, Oda K et al (2021) Changes in body composition and low blood urea nitrogen level related to an increase in the prevalence of fatty liver over 20 years: a cross-sectional study. Hepatol Res 51:570\u2013579","journal-title":"Hepatol Res"},{"key":"9542_CR39","doi-asserted-by":"crossref","unstructured":"Gonzalez A, Huerta-Salgado C, Orozco-Aguilar J et al (2020) Role of oxidative stress in hepatic and extrahepatic dysfunctions during nonalcoholic fatty liver disease (NAFLD). Oxidative Medicine and Cellular Longevity 2020","DOI":"10.1155\/2020\/1617805"},{"key":"9542_CR40","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1053\/j.gastro.2020.01.049","volume":"158","author":"J Aron-Wisnewsky","year":"2020","unstructured":"Aron-Wisnewsky J, Warmbrunn MV, Nieuwdorp M, Clement K (2020) Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity? Gastroenterology 158:1881\u20131898","journal-title":"Gastroenterology"},{"key":"9542_CR41","first-page":"3925","volume":"83","author":"C Karlsson","year":"1998","unstructured":"Karlsson C, Lindell K, Ottosson M, Sj\u00f6str\u00f6m L, Carlsson Br, Carlsson LMS (1998) Human adipose tissue expresses angiotensinogen and enzymes required for its Conversion to Angiotensin II1. J Clin Endocrinol Metabolism 83:3925\u20133929","journal-title":"J Clin Endocrinol Metabolism"},{"key":"9542_CR42","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3390\/biomedicines9101405","volume":"9","author":"M Yang","year":"2021","unstructured":"Yang M, Geng C-A, Liu X, Guan M (2021) Lipid disorders in NAFLD and chronic kidney disease. Biomedicines 9:1405\u20131405","journal-title":"Biomedicines"},{"key":"9542_CR43","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3390\/biomedicines9101405","volume":"9","author":"M Yang","year":"2021","unstructured":"Yang M, Geng C-A, Liu X, Guan M (2021) Lipid disorders in NAFLD and chronic kidney disease. Biomedicines 9:1405","journal-title":"Biomedicines"},{"key":"9542_CR44","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41598-017-01751-y","volume":"7","author":"D Zhou","year":"2017","unstructured":"Zhou D, Pan Q, Shen F et al (2017) Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota. Sci Rep 7:1529","journal-title":"Sci Rep"},{"key":"9542_CR45","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jnutbio.2012.01.014","volume":"24","author":"S Wagnerberger","year":"2013","unstructured":"Wagnerberger S, Spruss A, Kanuri G et al (2013) Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model. J Nutr Biochem 24:531\u2013538","journal-title":"J Nutr Biochem"},{"key":"9542_CR46","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jff.2015.10.022","volume":"20","author":"H Song","year":"2016","unstructured":"Song H, Han W, Yan F, Xu D, Chu Q, Zheng X (2016) Dietary Phaseolus vulgaris extract alleviated diet-induced obesity, insulin resistance and hepatic steatosis and alters gut microbiota composition in mice. J Funct Foods 20:236\u2013244","journal-title":"J Funct Foods"},{"key":"9542_CR47","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/md16120498","volume":"16","author":"X Wan","year":"2018","unstructured":"Wan X, Li T, Liu D et al (2018) Effect of marine microalga Chlorella pyrenoidosa ethanol extract on lipid metabolism and gut microbiota composition in high-fat diet-fed rats. Mar Drugs 16:498","journal-title":"Mar Drugs"},{"key":"9542_CR48","doi-asserted-by":"crossref","first-page":"904001","DOI":"10.3389\/fendo.2022.904001","volume":"13","author":"L Lin","year":"2022","unstructured":"Lin L, Tan W, Pan X, Tian E, Wu Z, Yang J (2022) Metabolic syndrome-related kidney injury: a review and update. Front Endocrinol 13:904001\u2013904001","journal-title":"Front Endocrinol"},{"key":"9542_CR49","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1042\/CS20180148","volume":"132","author":"K Wanchai","year":"2018","unstructured":"Wanchai K, Yasom S, Tunapong W et al (2018) Probiotic Lactobacillus paracasei HII01 protects rats against obese-insulin resistance-induced kidney injury and impaired renal organic anion transporter 3 function. Clin Sci 132:1545\u20131563","journal-title":"Clin Sci"},{"key":"9542_CR50","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41598-020-80063-0","volume":"11","author":"W Zhang","year":"2021","unstructured":"Zhang W, Miikeda A, Zuckerman J et al (2021) Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice. Sci Rep 11:518\u2013518","journal-title":"Sci Rep"},{"key":"9542_CR51","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/j.cmet.2021.06.014","volume":"33","author":"H Zhu","year":"2021","unstructured":"Zhu H, Cao C, Wu Z et al (2021) The probiotic L. Casei Zhang slows the progression of acute and chronic kidney disease. Cell Metabol 33:1926\u20131942","journal-title":"Cell Metabol"},{"key":"9542_CR52","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4162\/nrp.2008.2.4.204","volume":"2","author":"HS Lee","year":"2008","unstructured":"Lee HS, Park HJ, Kim MK (2008) Effect of Chlorella vulgaris on lipid metabolism in Wistar rats fed high fat diet. Nutr Res Pract 2:204\u2013210","journal-title":"Nutr Res Pract"},{"key":"9542_CR53","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3390\/biom12101443","volume":"12","author":"M Mounir","year":"2022","unstructured":"Mounir M, Ibijbijen A, Farih K, Rabetafika HN, Razafindralambo HL (2022) Synbiotics and their antioxidant properties, mechanisms, and benefits on human and animal health: a narrative review. Biomolecules 12:1443","journal-title":"Biomolecules"},{"key":"9542_CR54","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3390\/antiox12071342","volume":"12","author":"Q Li","year":"2023","unstructured":"Li Q, Zheng T, Ding H et al (2023) Exploring the benefits of Probiotics in Gut inflammation and Diarrhea\u2014from an antioxidant perspective. Antioxidants 12:1342","journal-title":"Antioxidants"},{"key":"9542_CR55","doi-asserted-by":"crossref","unstructured":"Kleniewska P, Hoffmann A, Pniewska E, Pawliczak R (2016) The influence of probiotic Lactobacillus casei in combination with prebiotic inulin on the antioxidant capacity of human plasma. Oxidative medicine and cellular longevity 2016","DOI":"10.1155\/2016\/1340903"},{"key":"9542_CR56","doi-asserted-by":"crossref","first-page":"e00484","DOI":"10.1128\/Spectrum.00484-21","volume":"9","author":"S Keshavarz Azizi Raftar","year":"2021","unstructured":"Keshavarz Azizi Raftar S, Ashrafian F, Yadegar A et al (2021) The protective effects of live and pasteurized Akkermansia muciniphila and its extracellular vesicles against HFD\/CCl4-induced liver injury. Microbiol Spectr 9:e00484\u2013e00421","journal-title":"Microbiol Spectr"},{"key":"9542_CR57","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1469-7580.2008.00902.x","volume":"212","author":"ME Altunkaynak","year":"2008","unstructured":"Altunkaynak ME, \u00d6zbek E, Altunkaynak BZ, Can \u0130, Unal D, Unal B (2008) The effects of high-fat diet on the renal structure and morphometric parametric of kidneys in rats. J Anat 212:845\u2013852","journal-title":"J Anat"},{"key":"9542_CR58","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1113\/jphysiol.2005.084947","volume":"565","author":"JA Armitage","year":"2005","unstructured":"Armitage JA, Lakasing L, Taylor PD et al (2005) Developmental programming of aortic and renal structure in offspring of rats fed fat-rich diets in pregnancy. J Physiol 565:171\u2013184","journal-title":"J Physiol"},{"key":"9542_CR59","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/ndt\/gfy382","volume":"35","author":"C-A Schulz","year":"2020","unstructured":"Schulz C-A, Engstr\u00f6m G, Nilsson J et al (2020) Plasma kidney injury molecule-1 (p-KIM-1) levels and deterioration of kidney function over 16 years. Nephrol Dialysis Transplantation 35:265\u2013273","journal-title":"Nephrol Dialysis Transplantation"},{"key":"9542_CR60","doi-asserted-by":"crossref","unstructured":"Allegretti AS, Parada XV, Endres P et al (2021) Urinary NGAL as a diagnostic and prognostic marker for acute kidney injury in cirrhosis: a prospective study. Clinical and translational gastroenterology 12","DOI":"10.14309\/ctg.0000000000000382"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09542-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09542-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09542-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T03:06:08Z","timestamp":1738724768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09542-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,5]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9542"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09542-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,5]]},"assertion":[{"value":"12 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Research Ethics Committee of the Islamic Azad University-Arsanjan Branch (Fars Province) has ethically confirmed the study (Ethics Code: IR.IAU.A.REC.1402.065).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors affirm that they don\u2019t have competitive interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"613"}}